AzTrials
AzTrials

Wound HealingNCT00825851

Effect of Smoking, Abstention and Nicotine Replacement Therapy on Wound Healing

A study testing Transdermal nicotine patch, Smoking cessation and Continuous smoking in people with Wound Healing, run by Bispebjerg Hospital at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim was to determine the wound healing capacity in healthy never smokers and smokers who continue to smoke, or quit smoking using transdermal nicotine patch versus placebo patch. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Wound Healing
What is being tested?
Transdermal nicotine patch, Smoking cessation and Continuous smoking
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
78 participants
Where
1 siteDenmark
Study dates
Aug 2000to Jan 2001
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • daily smokers smoking between 15-25 cigarettes per day and never smokers

Who cannot join

  • chronic medical disease
  • atopic dermatitis or other skin disease
  • pregnancy
  • menopause
  • allergy to dressings or patches
  • current or recent medication with corticosteroids or NSAID

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Bispebjerg Hospital

    Copenhagen, 2400

Other trials in Denmark

About this study

The aim was to determine the wound healing capacity in healthy never smokers and smokers who continue to smoke, or quit smoking using transdermal nicotine patch versus placebo patch.

Read the detailed description

Two wound healing models were applied: the excisional skin biopsy model to study wound histology and the suction blister model to study epidermal regeneration and skin transudate. In addition blood sampling was made to validate compliance to the study arms and to study systemic markers of collagen metabolism and oxidative stress. In addition, wound infections and wound ruptures were recorded post hoc as complications to the excisional skin biopsy model were not expected to occur.

Conditions
Wound Healing
Being tested
Transdermal nicotine patch, Placebo patch, Smoking cessation, Continuous smoking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transdermal nicotine patchDrug

    Also called Nicorette patch

    15mg/16h + 10mg/16h to be used 24h

  • Placebo patchDrug

  • Smoking cessationBehavioural

  • Continuous smokingBehavioural

    subjects smoke 20 cigarettes per day

Study groups in NCT00825851
Study groupRoleWhat they receive
continuous smokingActive comparatorsubjects smoke 20 cigarettes per day
Receives: Behavioral: Continuous smoking
smoking cessation and NRTActive comparatorsubjects quit smoking and use transdermal nicotine patch
Receives: Drug: Transdermal nicotine patch; Behavioral: Smoking cessation
smoking cessation and placebo patchPlacebo comparatorsubjects quit smoking and use placebo patch
Receives: Drug: Placebo patch; Behavioral: Smoking cessation
never smokersNo interventionsubjects being never smokers and who refrain from smoking

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. wound healing

    Measured: 1, 4, 8, and 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jan 2009 (estimated)
  2. Study startAug 2000
  3. Primary completionDec 2000
  4. Study completionJan 2001

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
78 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00825851
Sponsor's protocol ID
smokaw_3
Status last verified
Jan 2009
First submitted
20 Jan 2009
Last updated
21 Jan 2009
Results posted
No
Data monitoring committee
No

Publications

  • Sorensen LT, Karlsmark T, Gottrup F. Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg. 2003 Jul;238(1):1-5. doi: 10.1097/01.SLA.0000074980.39700.31.

    PubMed 12832959

Questions about this trial

What is this clinical trial studying?

A study testing Transdermal nicotine patch, Smoking cessation and Continuous smoking in people with Wound Healing, run by Bispebjerg Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jan 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

wound healing (time frame: 1, 4, 8, and 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00825851, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jan 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in